Edesa Biotech Inc (EDSA)
5.18
-0.05 -0.96%
NASDAQ
Jul 23, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.87 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -8.678M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 68.66M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 157.99 |
| PE Ratio | -- |
| Price to Book Value | 3.563 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -7.182M |
| Return on Equity | Upgrade |
View All EDSA News
News
-
WireHeadlineTime (ET)
-
MT Newswires07/13 09:59
-
SA Breaking News07/13 09:04
-
Accesswire07/13 08:10
-
Yahoo06/24 02:50
-
Accesswire06/23 07:55
-
PR Newswire06/18 10:57
-
Yahoo06/18 08:50
-
MT Newswires06/18 08:23
-
SA Breaking News06/18 08:19
-
SA Breaking News06/18 08:01
-
Accesswire06/18 07:45
-
Accesswire06/08 08:00
-
Yahoo06/04 06:52
-
Yahoo06/03 08:47
-
SA Breaking News06/03 07:57
-
Accesswire06/03 07:30
-
Accesswire05/28 08:00
-
Yahoo05/18 08:27
-
SA Breaking News05/14 08:49
-
MT Newswires05/14 08:01
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/12/2021 | Earnings Results | Q3 2021 Earnings Results |
| 05/14/2021 | Earnings Results | Q2 2021 Earnings Results |
| 04/22/2021 10:30 EST | AGM | 2020 Annual General Meeting |
| 02/16/2021 | Earnings Results | Q1 2021 Earnings Results |
| 12/07/2020 | Earnings Results | Q4 2020 Earnings Results |
| 08/12/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
- URL: https://www.edesabiotech.com
- Investor Relations URL: http://ir.stellarbiotechnologies.com/
- HQ State/Province: Ontario
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 12, 2021
- Last Earnings Release: May. 14, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 5.18 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EDSA Tweets Stocktwits
Advertisement
